Basic & Clinical Medicine ›› 2010, Vol. 30 ›› Issue (11): 1134-1137.

• 研究论文 • Previous Articles     Next Articles

HMGS and HMGR from Streptococcus pneumoniae is Facilitated to Screen Candidate Inhibitors

Ya-li BEN, Gu-zhen CUI, De-li LIU   

  1. Jianghan University
  • Received:2009-09-03 Revised:2010-03-11 Online:2010-11-05 Published:2010-11-05

Abstract: Objective The 3-hydroxy-3-methylglutaryl-coenzyme A synthase and reductase (HMGS and HMGR) were analyzed by their dynamics and function; Methods The genes of HMGS and HMGR were cloned from S.pneumoniae and expressed. Their inhibition effect was tested by lovastatin and the candidate inhibitors; Results Lovastatin can inhibit HMGS, but not do for HMGR. It is more effective in the virtual screening with the reacting product catalyzed by HMGS instead of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA); Conclusions Lovastatin is a kind of competing inhibitor targeted for HMGR. The product can be used to screen preliminarily plentiful candidate inhibitors and develop new inhibitors with more specific and stronger function.

Key words: Streptococcus pneumoniae, HMG-CoA synthase, HMG-CoA reductase, Kinetic characteristics, Function